Gender-dependent cancer-specific survival following radical cystectomy

World Journal of Urology

Volumn 30, Issue 5, 2012, Pages 707-713

  May, Matthias ^a   Stief, Christian ^b   Brookman May, Sabine ^c   Otto, Wolfgang ^c   Gilfrich, Christian ^a   Roigas, Jan ^d   Zacharias, Mario ^e   Wieland, Wolf F ^c   Fritsche, Hans Martin ^c   Hofstädter, Ferdinand ^c   Burger, Maximilian ^c  

^a Urologische Klinik   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d VIVANTES KLINIKUM AM URBAN   (Germany)

^e VIVANTES HOSPITAL   (Germany)

Author keywords

Gender; Prognosis; Radical cystectomy; Urothelial cancer of the bladder

Indexed keywords

AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEX RATIO; TRANSITIONAL CELL CARCINOMA; URINARY DIVERSION; UROTHELIUM;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; URINARY BLADDER NEOPLASMS; URINARY DIVERSION; UROTHELIUM;

EID: 84868591610     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0773-1     Document Type: Article

References (30)

1. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. [Epub ahead of print].
2. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA, European Association of Urology (EAU) (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59(6): 1009-1018.
3. Horstmann M, Witthuhn R, Falk M, Stenzl A (2008) Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med 5(4): 385-394.
4. Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4, 430 patients. J Urol 184(3): 888-894.
5. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55(6): 876-880.
6. Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115(1): 68-74.
7. Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183(1): 87-93.
8. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3): 300-308.
9. Scosyrev E, Trivedi D, Messing E (2010) Female bladder cancer: incidence, treatment, and outcome. Curr Opin Urol 20(5): 404-408.
10. Johnson EK, Daignault S, Zhang Y, Lee CT (2008) Patterns of haematuria referral to urologists: does a gender disparity exist? Urology 72(3): 498-502.
11. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS, Urologic Diseases in America Project (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115(5): 988-996.
12. May M, Nitzke T, Helke C, Vogler H, Hoschke B (2004) Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 38(3): 231-235.
13. Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175(4): 1262-1267.
14. Maclennan SJ, Maclennan SJ, Imamura M, Omar MI, Vale L, Lam T, Royle P, Royle J, Swami S, Pickard R, McClinton S, Griffiths TR, Dahm P, N'dow J, The UCAN Care Pathway Development Group (2011) Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World J Urol 29(3): 291-301.
15. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P (1998) The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 34(14): 2271-2278.
16. Svatek RS, Shariat SF, Dinney CP, Novara G, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Muller SC, Izawa JI, Skinner E, Stief CG, Ficarra V, Volkmer BG, Montorsi F, Isbarn H, Lerner SP, Sagalowsky AI, Schoenberg MP (2009) Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study. J Urol 181(4, Supplement 1): 629.
17. Jeldres C, Isbarn H, Capitanio U, Baillargeon-Gagne S, Bhojani N, Shariat SF, Suardi N, Gallina A, Montorsi F, Saad F, Perrotte P, Karakiewicz PI (2009) Gender is an important predictor of cancer-specific survival in patient with transitional cell carcinoma after radical cystectomy. J Urol 181(4, Supplement 1): 635.
18. Datta GD, Neville B, Datta NS, Earle C (2006) Gender disparities in bladder cancer survival: an assessment of sociodemographic factors. AACR Meet Abst B38.
19. Leliveld AM, Doornweerd BH, Bastiaannet E, Schaapveld M, de Jong IJ (2010) Treatment and outcome in muscle invasive bladder cancer: a population-based survey. World J Urol 28(4): 439-444.
20. Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M (2011) Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World J Urol. [Epub ahead of print].
21. Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF (2011) Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol 185(2): 456-461.
22. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176(6 Pt 1): 2414-2422 (discussion 2422).
23. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG (2009) Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol 181(5): 2052-2058 (discussion 2058-2059).
24. May M, Helke C, Nitzke T, Vogler H, Hoschke B (2004) Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 72(2): 103-111.
25. Alkhateeb SS, van Rhijn BW, Finelli A, van der Kwast T, Evans A, Hanna S, Vajpeyi R, Fleshner NE, Jewett MA, Zlotta AR (2010) Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors. J Urol 184(1): 81-86.
26. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51(1): 152-160.
27. Manoharan M, Katkoori D, Kishore TA, Jorda M, Luongo T, Soloway MS (2010) Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? World J Urol 28(2): 233-237.
28. Puente D, Malats N, Cecchini L, Tardón A, García-Closas R, Serra C, Carrato A, Sala M, Boixeda R, Dosemeci M, Real FX, Kogevinas M, EPICURO Study Group Investigators (2003) Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43(1): 53-62.
29. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM (2011) Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993-2002), stage and grade (1993-2007). J Urol 185(5): 1631-1636.
30. May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol. [Epub ahead of print].